Non-inferiority Study of a New Therapeutic Strategy for Gout: Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration - FEFACRIGOU Trial
Latest Information Update: 03 Sep 2024
At a glance
- Drugs Febuxostat (Primary)
- Indications Gout
- Focus Therapeutic Use
- Acronyms FEFACRIGOU
- 09 Nov 2021 Location assumed from sponsor. Based on the 1st point of inclusion I have assumed that it may be a new onset. Route assumed from RDI. Please update further when more information is available.
- 09 Nov 2021 New trial record